History & Culture
Bioendo founded in 1978.
In 1985, Research on Quality of TAL and Pilot Production Process rewarded the FIRST GRADE Chinese Health Ministry Innovation Award.
In 1988, our product TAL reagent obtained the production approval license of the Ministry of Health of the People's Republic of China. Bioendo became the first TAL manufacturer licensed by CFDA.
In 1995, Commercialized the endotoxin-specific TAL.
In 2004, commercialized the chromogenic TAL assay kit.
In 2007, obtained certification of ISO9001 and ISO13485 quality management system, developed efficient, automatic detection system for bacterial endotoxins and Fungi (1,3)-β-D-glucan).
In 2009, launched new products: Endotoxin Assay Kit for Water and Dialysate; Endotoxin Assay Kit for Biological Products (Vaccine).
In 2010, our product TAL reagent was used by China National Institute of Drug Control as “References Standard” of TAL Reagent at China.
In 2011, Endotoxin Assay Kit for Human Plasma and Fungi (1,3)-β-D-glucan Assay Kit registered at CFDA for the clinical diagnosis kit for gram negative bacterial infection and invasive fungal disease infection diagnosis.
In 2012, launched new product: USP Standard Gel Clot TAL Single Test in Test Tubes.
In 2013, our project “Application of Chromogenic TAL Kit on Rapid Bacterial Endotoxin Detection during Clinical Diagnosis” got approval from National Technology-based Enterprises Technological Innovation Fund and started to do related development and production.
In 2020, commercialized new product: Dry Heat Sterilized Endotoxin Challenge Vials (Endotoxin Indicator).
In 2021, introduce robot technology to endotoxin detection. Launched new product: Micro Kinetic Chromogenic Tachypleus Amebocyte Lysate Assay Kit for Endotoxin Detection.
In 2022, started to use recombination techniques for endotoxin testing. Launched new product: BioendoTM Recombinant Factor C Endotoxin Test Kit (Fluorescent Assay).
